The rapid detection of procalcitonin in septic serum using immunoaffinity MALDI chips.
Immunoaffinity
Ion soft landing
MALDI-TOF
Procalcitonin
Sepsis
Journal
Clinical proteomics
ISSN: 1542-6416
Titre abrégé: Clin Proteomics
Pays: England
ID NLM: 101184586
Informations de publication
Date de publication:
11 May 2023
11 May 2023
Historique:
received:
18
08
2022
accepted:
27
04
2023
medline:
12
5
2023
pubmed:
12
5
2023
entrez:
11
5
2023
Statut:
epublish
Résumé
Sepsis is a common worldwide health condition with high mortality. It is caused by a dysregulated immune response to the pathogen. Severe infections resulting in sepsis can be also determined by monitoring several bloodstream biomarkers, one of them being pro-hormone procalcitonin (PCT). PCT concentration in the bloodstream correlates well with sepsis and in severe cases increases up to a thousand times from the healthy physiological values in a short time. In this study, we developed a rapid technique for PCT detection by MALDI-TOF mass spectrometry, that uses in-situ enrichment directly on the specialized immuno MALDI chips that are utilized as MALDI plates. The method's ability to detect PCT was confirmed by comparing the results with LC-MS bottom-up workflow. The new method detects intact PCT by its m/z and uncovers its alternations in septic serum. The MALDI chips used for the detection of PCT were prepared by ambient ion soft landing of anti-PCT antibody on an ITO glass slide. The chips were used for the development of the rapid MALDI-TOF MS method. A parallel method based on affinity enrichment on magnetic beads followed by LC-MS/MS data-dependent peptide microsequencing was used to prove PCT presence in the sample. All samples were also tested by ELISA to determine PCT concentration prior to analyzing them by mass spectrometry methods. The MALDI chip method was optimized using recombinant PCT spiked into the human serum. The PCT detection limit was 10 ng/mL. The optimized method was used to analyze 13 sera from patients suffering sepsis. The PCT results were confirmed by LC-MS/MS. The measurement of the intact PCT by the MALDI chip method revealed that sera of patients with severe sepsis have other forms of PCT present, which show post-processing of the primary sequence by cleavage of PCT, resulting in the formation of N and C termini fragments. Procalcitonin from human serum was successfully enriched and detected using immunoaffinity MALDI chips. The intact PCT was characterized in 13 septic patients. The method is more specific compared to non-MS-based immunoaffinity techniques and allows observation of different variants of PCT in septic patients.
Sections du résumé
BACKGROUND
BACKGROUND
Sepsis is a common worldwide health condition with high mortality. It is caused by a dysregulated immune response to the pathogen. Severe infections resulting in sepsis can be also determined by monitoring several bloodstream biomarkers, one of them being pro-hormone procalcitonin (PCT). PCT concentration in the bloodstream correlates well with sepsis and in severe cases increases up to a thousand times from the healthy physiological values in a short time. In this study, we developed a rapid technique for PCT detection by MALDI-TOF mass spectrometry, that uses in-situ enrichment directly on the specialized immuno MALDI chips that are utilized as MALDI plates. The method's ability to detect PCT was confirmed by comparing the results with LC-MS bottom-up workflow. The new method detects intact PCT by its m/z and uncovers its alternations in septic serum.
METHODS
METHODS
The MALDI chips used for the detection of PCT were prepared by ambient ion soft landing of anti-PCT antibody on an ITO glass slide. The chips were used for the development of the rapid MALDI-TOF MS method. A parallel method based on affinity enrichment on magnetic beads followed by LC-MS/MS data-dependent peptide microsequencing was used to prove PCT presence in the sample. All samples were also tested by ELISA to determine PCT concentration prior to analyzing them by mass spectrometry methods.
RESULTS
RESULTS
The MALDI chip method was optimized using recombinant PCT spiked into the human serum. The PCT detection limit was 10 ng/mL. The optimized method was used to analyze 13 sera from patients suffering sepsis. The PCT results were confirmed by LC-MS/MS. The measurement of the intact PCT by the MALDI chip method revealed that sera of patients with severe sepsis have other forms of PCT present, which show post-processing of the primary sequence by cleavage of PCT, resulting in the formation of N and C termini fragments.
CONCLUSIONS
CONCLUSIONS
Procalcitonin from human serum was successfully enriched and detected using immunoaffinity MALDI chips. The intact PCT was characterized in 13 septic patients. The method is more specific compared to non-MS-based immunoaffinity techniques and allows observation of different variants of PCT in septic patients.
Identifiants
pubmed: 37170190
doi: 10.1186/s12014-023-09410-3
pii: 10.1186/s12014-023-09410-3
pmc: PMC10176672
doi:
Types de publication
Journal Article
Langues
eng
Pagination
20Subventions
Organisme : Medical Research Foundation of the Czech Republic
ID : NV19-05-00541
Organisme : Czech Academy of Sciences
ID : RVO61388971
Organisme : Charles University Grant Agency
ID : 384021
Organisme : National Recovery Plan
ID : LX22NPO5103
Organisme : MEYS CR
ID : LM2018127
Organisme : European Regional Development Fund-Project "UP CIISB "
ID : CZ.02.1.01/0.0/0.0/18_046/0015974
Informations de copyright
© 2023. The Author(s).
Références
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Anal Chem. 2011 Apr 1;83(7):2648-54
pubmed: 21410137
Clin Chem. 2016 Jan;62(1):99-110
pubmed: 26467505
Clin Chem. 2016 Jan;62(1):270-8
pubmed: 26482160
Peptides. 2001 Dec;22(12):2099-103
pubmed: 11786196
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319
Biosens Bioelectron. 2019 Jan 15;124-125:205-215
pubmed: 30388563
J Clin Endocrinol Metab. 2004 Apr;89(4):1512-25
pubmed: 15070906
Nano Lett. 2012 May 9;12(5):2452-8
pubmed: 22530980
Clin Chem. 2018 Sep;64(9):1319-1326
pubmed: 30002097
J Intensive Care. 2017 Aug 3;5:51
pubmed: 28794881
Anal Bioanal Chem. 2021 Aug;413(19):4707-4725
pubmed: 33987701
Lancet. 2018 Jul 7;392(10141):75-87
pubmed: 29937192
Clin Biochem Rev. 2017 Apr;38(2):59-68
pubmed: 29332972
J Thorac Dis. 2020 Feb;12(Suppl 1):S5-S15
pubmed: 32148921
J Mass Spectrom. 2012 Oct;47(10):1294-302
pubmed: 23019160
Anal Chem. 2016 Sep 6;88(17):8526-34
pubmed: 27478994
J Am Soc Mass Spectrom. 2004 Dec;15(12):1874-84
pubmed: 15589764
Intensive Care Med. 2017 Mar;43(3):304-377
pubmed: 28101605
ScientificWorldJournal. 2010 Oct 01;10:1941-6
pubmed: 20890583
Crit Care Med. 2006 Oct;34(10):2596-602
pubmed: 16915118
Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72
pubmed: 26414292